Elizabeth O’Hearn

4.0k total citations
25 papers, 2.7k citations indexed

About

Elizabeth O’Hearn is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Elizabeth O’Hearn has authored 25 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cellular and Molecular Neuroscience, 13 papers in Molecular Biology and 6 papers in Neurology. Recurrent topics in Elizabeth O’Hearn's work include Genetic Neurodegenerative Diseases (13 papers), Neuroscience and Neuropharmacology Research (9 papers) and Mitochondrial Function and Pathology (6 papers). Elizabeth O’Hearn is often cited by papers focused on Genetic Neurodegenerative Diseases (13 papers), Neuroscience and Neuropharmacology Research (9 papers) and Mitochondrial Function and Pathology (6 papers). Elizabeth O’Hearn collaborates with scholars based in United States, France and Portugal. Elizabeth O’Hearn's co-authors include Mark E. Molliver, M.E. Molliver, Giuseppe Battaglia, EB De Souza, MJ Kuhar, Russell L. Margolis, Laura A. Mamounas, E B De Souza, S.Y. Yeh and M J Kuhar and has published in prestigious journals such as Nature Genetics, Journal of Neuroscience and American Journal of Psychiatry.

In The Last Decade

Elizabeth O’Hearn

25 papers receiving 2.6k citations

Peers

Countries citing papers authored by Elizabeth O’Hearn

Since Specialization

Citations

This map shows the geographic impact of Elizabeth O’Hearn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth O’Hearn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth O’Hearn more than expected).

Fields of papers citing papers by Elizabeth O’Hearn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth O’Hearn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth O’Hearn. The network helps show where Elizabeth O’Hearn may publish in the future.

Co-authorship network of co-authors of Elizabeth O’Hearn

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth O’Hearn. A scholar is included among the top collaborators of Elizabeth O’Hearn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth O’Hearn. Elizabeth O’Hearn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Spinocerebellar ataxia type 12 2011 ·Handbook of clinical neurology ·Elizabeth O’Hearn, Susan E. Holmes, Russell L. Margolis	41
2	Evidence of a Common Founder for SCA12 in the Indian Population 2005 ·Annals of Human Genetics ·S. Bahl, (unknown), Uma Mittal, M.P. Sachdeva, A.K. Kalla, Susan E. Holmes, Elizabeth O’Hearn, Russel L. Margolis, Sanjeev Jain, Achal Kumar Srivastava, Mitali Mukerji	52
3	Clinical signs and symptoms in a large hereditary spastic paraparesis pedigree with a novel spastin mutation 2004 ·Movement Disorders ·Anthony P. Nicholas, Elizabeth O’Hearn, Susan E. Holmes, Dung‐Tsa Chen, Russell L. Margolis	5
4	Administration of a non-NMDA antagonist, gyki 52466, increases excitotoxic Purkinje cell degeneration caused by ibogaine 2004 ·Neuroscience ·Elizabeth O’Hearn, M.E. Molliver	11
5	Cognitive Impairments in Cerebellar Degeneration: A Comparison With Huntington’s Disease 2004 ·Journal of Neuropsychiatry ·Jason Brandt, Iracema Leroi, Elizabeth O’Hearn, Adam Rosenblatt, Russell L. Margolis	25
6	Phenotypic features of Huntington's disease‐like 2 2003 ·Movement Disorders ·Ruth H. Walker, Joseph Jankovic, Elizabeth O’Hearn, Russell L. Margolis	41
7	The alkylating agent penclomedine induces degeneration of purkinje cells in the rat cerebellum 2003 ·Investigational New Drugs ·Séamus O’Reilly, Elizabeth O’Hearn, Robert F. Struck, Eric K. Rowinsky, Mark E. Molliver	6
8	Psychopathology in Patients With Degenerative Cerebellar Diseases: A Comparison to Huntington’s Disease 2002 ·American Journal of Psychiatry ·Iracema Leroi, Elizabeth O’Hearn, Laura Marsh, Constantine G. Lyketsos, Adam Rosenblatt, Christopher A. Ross, Jason Brandt, Russell L. Margolis	92
9	A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion 2001 ·Annals of Neurology ·Russell L. Margolis, Elizabeth O’Hearn, Adam Rosenblatt, Virginia L. Willour, Susan E. Holmes, Mary L. Franz, Colleen Callahan, Hyon S. Hwang, Juan C. Troncoso, Christopher A. Ross	123
10	Psychiatric syndromes in cerebellar degeneration 2001 ·International Review of Psychiatry ·Iracema Leroi, Elizabeth O’Hearn, Russell L. Margolis	6
11	A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion 2001 ·Annals of Neurology ·Russell L. Margolis, Elizabeth O’Hearn, Adam Rosenblatt, Virginia L. Willour, Susan E. Holmes, Mary L. Franz, Colleen Callahan, Hyon S. Hwang, Juan C. Troncoso, Christopher A. Ross	72
12	Differential neuronal localizations and dynamics of phosphorylated and unphosphorylated type 1 inositol 1,4,5-trisphosphate receptors 2001 ·Neuroscience ·Andrew A. Pieper, Daniel J. Brat, Elizabeth O’Hearn, (unknown), Adam Kaplin, Ken Takahashi, Joel Greenberg, David D. Ginty, M.E. Molliver, Solomon H. Snyder	29
13	A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease–like 2 2001 ·Nature Genetics ·Susan E. Holmes, Elizabeth O’Hearn, Adam Rosenblatt, Colleen Callahan, Hyon S. Hwang, Roxann Ingersoll, Adam Fleisher, Giovanni Stévanin, Alexis Brice, Nicholas T. Potter, Christopher A. Ross, Russell L. Margolis	206
14	The Olivocerebellar Projection Mediates Ibogaine-Induced Degeneration of Purkinje Cells: A Model of Indirect, Trans-Synaptic Excitotoxicity 1997 ·Journal of Neuroscience ·Elizabeth O’Hearn, Mark E. Molliver	132
15	Excitotoxic insult due to ibogaine leads to delayed induction of neuronal NOS in Purkinje cells 1995 ·Neuroreport ·Elizabeth O’Hearn, (unknown), M.E. Molliver	70
16	Degeneration of purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline 1993 ·Neuroscience ·Elizabeth O’Hearn, M.E. Molliver	192
17	Dual serotoninergic projections to forebrain in the rat: Morphologically distinct 5‐HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives 1991 ·The Journal of Comparative Neurology ·Laura A. Mamounas, Crystal A. Mullen, Elizabeth O’Hearn, Mark E. Molliver	202
18	Neurotoxicity of MDMA and Related Compounds: Anatomic Studies^a 1990 ·Annals of the New York Academy of Sciences ·Mark E. Molliver, Urs V. Berger, Laura A. Mamounas, Derek C. Molliver, Elizabeth O’Hearn, Mary Ann Wilson	209
19	Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity 1988 ·Journal of Neuroscience ·Elizabeth O’Hearn, Giuseppe Battaglia, EB De Souza, MJ Kuhar, (unknown)	445
20	3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. 1987 ·Journal of Pharmacology and Experimental Therapeutics ·Giuseppe Battaglia, S.Y. Yeh, Elizabeth O’Hearn, M.E. Molliver, M J Kuhar, E B De Souza	384

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact